Source link : https://san-francisco-news.com/2026/02/14/merck-set-for-strong-growth-even-as-keytruda-faces-patent-expiry/
Merck remains confident ahead of Keytruda’s loss of exclusivity, projecting growth through new drug developments and expanded indications, signaling resilience amid increasing competition.
—-
Author : Jackson Lee
Publish date : 2026-02-14 01:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8